Skip to main content
Top
Gepubliceerd in: Quality of Life Research 9/2020

13-04-2020

Trends and predictors of multidimensional health-related quality of life after living donor kidney transplantation

Auteurs: John D. Peipert, Juan Carlos Caicedo, John J. Friedewald, Michael M. I. Abecassis, David Cella, Daniela P. Ladner, Zeeshan Butt

Gepubliceerd in: Quality of Life Research | Uitgave 9/2020

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Living donor kidney transplant (LDKT) imparts the best graft and patient survival for most end-stage kidney disease (ESKD) patients. Yet, there remains variation in post-LDKT health-related quality of life (HRQOL). Improved understanding of post-LDKT HRQOL can help identify patients for interventions to maximize the benefit of LDKT.

Methods

For 477 LDKT recipients transplanted between 11/2007 and 08/2016, we assessed physical, mental, social, and kidney-targeted HRQOL pre-LDKT, as well as 3 and 12 months post-operatively using the SF-36, Kidney Disease Quality of Life—Short Form (KDQOL-SF), and the Functional Assessment of Cancer Therapy—Kidney Symptom Index 19 item version (FKSI-19). We then examined trajectories of each HRQOL domain using latent growth curve models (LGCMs). We also examined associations between decline in HRQOL from 3 months to 12 months post-LDKT and death censored graft failure (DCGF) using Cox regression.

Results

Large magnitude effects (d > 0.80) were observed from pre- to post-LDKT change on the SF-36 Vitality scale (d = 0.81) and the KDQOL-SF Burden of Kidney Disease (d = 1.05). Older age and smaller pre- to post-LDKT decreases in serum creatinine were associated with smaller improvements on many HRQOL scales across all domains in LGCMs. Higher DCGF rates were associated with worse physical [e.g., SF-36 PCSoblique hazard ratio (HR) 1.18; 95% CI 1.01–1.38], mental (KDQOL-SF Cognitive Function HR 1.27; 95% CI 1.00–1.62), and kidney-targeted (FKSI-19 HR: 1.18; 95% CI 1.00–1.38) HRQOL domains.

Conclusion

Clinical HRQOL monitoring may help identify patients who are most likely to have failing grafts and who would benefit from post-LDKT intervention.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference United States Renal Data System. (2018). 2018 USRDS annual data report: Epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. United States Renal Data System. (2018). 2018 USRDS annual data report: Epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
3.
go back to reference Peipert, J. D., Abecassis, M. M. I., Butt, Z., Cella, D., & Ladner, D. P. (2018). Response to "Shifting the conversation on outcomes reporting". American Journal of Transplantation, 18(9), 2368–2369.PubMed Peipert, J. D., Abecassis, M. M. I., Butt, Z., Cella, D., & Ladner, D. P. (2018). Response to "Shifting the conversation on outcomes reporting". American Journal of Transplantation, 18(9), 2368–2369.PubMed
4.
go back to reference Jofre, R., Lopez-Gomez, J. M., Moreno, F., Sanz-Guajardo, D., & Valderrabano, F. (1998). Changes in quality of life after renal transplantation. American Journal of Kidney Diseases, 32(1), 93–100.PubMed Jofre, R., Lopez-Gomez, J. M., Moreno, F., Sanz-Guajardo, D., & Valderrabano, F. (1998). Changes in quality of life after renal transplantation. American Journal of Kidney Diseases, 32(1), 93–100.PubMed
5.
go back to reference de Groot, I. B., Veen, J. I. E., van der Boog, P. J. M., van Dijk, S., Stiggelbout, A. M., Marang-van de Mheen, P. J., et al. (2013). Difference in quality of life, fatigue and societal participation between living and deceased donor kidney transplant recipients. Clinical Transplantation, 27(4), E415–E423.PubMed de Groot, I. B., Veen, J. I. E., van der Boog, P. J. M., van Dijk, S., Stiggelbout, A. M., Marang-van de Mheen, P. J., et al. (2013). Difference in quality of life, fatigue and societal participation between living and deceased donor kidney transplant recipients. Clinical Transplantation, 27(4), E415–E423.PubMed
6.
go back to reference Suzuki, A., Kenmochi, T., Maruyama, M., Akutsu, N., Iwashita, C., Otsuki, K., et al. (2012). Changes in quality of life in deceased versus living-donor kidney transplantations. Transplantation Proceedings, 44(1), 287–289.PubMed Suzuki, A., Kenmochi, T., Maruyama, M., Akutsu, N., Iwashita, C., Otsuki, K., et al. (2012). Changes in quality of life in deceased versus living-donor kidney transplantations. Transplantation Proceedings, 44(1), 287–289.PubMed
7.
go back to reference Hart, A., Smith, J. M., Skeans, M. A., Gustafson, S. K., Wilk, A. R., Castro, S., et al. (2019). OPTN/SRTR 2017 Annual data report. Kidney., 19(S2), 19–123. Hart, A., Smith, J. M., Skeans, M. A., Gustafson, S. K., Wilk, A. R., Castro, S., et al. (2019). OPTN/SRTR 2017 Annual data report. Kidney., 19(S2), 19–123.
8.
go back to reference Purnell, T. S., Luo, X., Crews, D. C., Bae, S., Ruck, J. M., Cooper, L. A., Grams, M. E., Henderson, M. L., Waldram, M. M., Johnson, M., & Segev, D. L. (9000). Neighborhood poverty and sex differences in live donor kidney transplant outcomes in the United States. Online first. Purnell, T. S., Luo, X., Crews, D. C., Bae, S., Ruck, J. M., Cooper, L. A., Grams, M. E., Henderson, M. L., Waldram, M. M., Johnson, M., & Segev, D. L. (9000). Neighborhood poverty and sex differences in live donor kidney transplant outcomes in the United States. Online first.
9.
go back to reference Axelrod, D. A., Dzebisashvili, N., Schnitzler, M. A., Salvalaggio, P. R., Segev, D. L., Gentry, S. E., et al. (2010). The interplay of socioeconomic status, distance to center, and interdonor service area travel on kidney transplant access and outcomes. Clinical Journal of the American Society of Nephrology, 5(12), 2276–2288.PubMedPubMedCentral Axelrod, D. A., Dzebisashvili, N., Schnitzler, M. A., Salvalaggio, P. R., Segev, D. L., Gentry, S. E., et al. (2010). The interplay of socioeconomic status, distance to center, and interdonor service area travel on kidney transplant access and outcomes. Clinical Journal of the American Society of Nephrology, 5(12), 2276–2288.PubMedPubMedCentral
10.
go back to reference Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., et al. (2010). The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. Journal of Clinical Epidemiology, 63(11), 1179–1194.PubMedPubMedCentral Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., et al. (2010). The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. Journal of Clinical Epidemiology, 63(11), 1179–1194.PubMedPubMedCentral
11.
go back to reference Tong, A., Gill, J., Budde, K., Marson, L., Reese, P. P., Rosenbloom, D., et al. (2017). Toward establishing core outcome domains for trials in kidney transplantation: report of the standardized outcomes in nephrology-kidney transplantation consensus workshops. Transplantation, 101(8), 1887–1896.PubMedPubMedCentral Tong, A., Gill, J., Budde, K., Marson, L., Reese, P. P., Rosenbloom, D., et al. (2017). Toward establishing core outcome domains for trials in kidney transplantation: report of the standardized outcomes in nephrology-kidney transplantation consensus workshops. Transplantation, 101(8), 1887–1896.PubMedPubMedCentral
12.
go back to reference Denis, F., Basch, E., Septans, A.-L., Bennouna, J., Urban, T., Dueck, A. C., et al. (2019). Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancereffects on survival of web-based symptom monitoring vs routine surveillance after lung cancer TreatmentLetters. JAMA, 321(3), 306–307.PubMedPubMedCentral Denis, F., Basch, E., Septans, A.-L., Bennouna, J., Urban, T., Dueck, A. C., et al. (2019). Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancereffects on survival of web-based symptom monitoring vs routine surveillance after lung cancer TreatmentLetters. JAMA, 321(3), 306–307.PubMedPubMedCentral
13.
go back to reference Basch, E., Deal, A. M., Dueck, A. C., et al. (2017). Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA, 318(2), 197–198.PubMedPubMedCentral Basch, E., Deal, A. M., Dueck, A. C., et al. (2017). Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA, 318(2), 197–198.PubMedPubMedCentral
14.
go back to reference Ortiz, F., Aronen, P., Koskinen, P. K., Malmstrom, R. K., Finne, P., Honkanen, E. O., et al. (2014). Health-related quality of life after kidney transplantation: who benefits the most? Transplant International, 27(11), 1143–1151.PubMed Ortiz, F., Aronen, P., Koskinen, P. K., Malmstrom, R. K., Finne, P., Honkanen, E. O., et al. (2014). Health-related quality of life after kidney transplantation: who benefits the most? Transplant International, 27(11), 1143–1151.PubMed
15.
go back to reference Bohlke, M., Marini, S. S., Rocha, M., Terhorst, L., Gomes, R. H., Barcellos, F. C., et al. (2009). Factors associated with health-related quality of life after successful kidney transplantation: a population-based study. Quality of Life Research, 18(9), 1185–1193.PubMed Bohlke, M., Marini, S. S., Rocha, M., Terhorst, L., Gomes, R. H., Barcellos, F. C., et al. (2009). Factors associated with health-related quality of life after successful kidney transplantation: a population-based study. Quality of Life Research, 18(9), 1185–1193.PubMed
16.
go back to reference Butt, Z., Yount, S. E., Caicedo, J. C., Abecassis, M. M., & Cella, D. (2008). Quality of life assessment in renal transplant: review and future directions. Clinical Transplantation, 22(3), 292–303.PubMed Butt, Z., Yount, S. E., Caicedo, J. C., Abecassis, M. M., & Cella, D. (2008). Quality of life assessment in renal transplant: review and future directions. Clinical Transplantation, 22(3), 292–303.PubMed
17.
go back to reference Hays, R. D., Kallich, J. D., Mapes, D. L., Coons, S. J., & Carter, W. B. (1994). Development of the kidney disease quality of life (KDQOL) instrument. Quality of Life Research, 3(5), 329–338.PubMed Hays, R. D., Kallich, J. D., Mapes, D. L., Coons, S. J., & Carter, W. B. (1994). Development of the kidney disease quality of life (KDQOL) instrument. Quality of Life Research, 3(5), 329–338.PubMed
18.
go back to reference Hays, R. D., Kallich, J. D., Mapes, D. L., Coons, S. J., Amin, N., Carter, W. B., et al. (1997). Kidney disease quality of life short form (KDQOL-SF): A manual for use and scoring (3rd ed.). Santa Monica, CA: RAND. Hays, R. D., Kallich, J. D., Mapes, D. L., Coons, S. J., Amin, N., Carter, W. B., et al. (1997). Kidney disease quality of life short form (KDQOL-SF): A manual for use and scoring (3rd ed.). Santa Monica, CA: RAND.
19.
go back to reference Farivar, S. S., Cunningham, W. E., & Hays, R. D. (2007). Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.I. Health Qual Life Outcomes, 5, 54. Farivar, S. S., Cunningham, W. E., & Hays, R. D. (2007). Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.I. Health Qual Life Outcomes, 5, 54.
20.
go back to reference Hagell, P., Westergren, A., & Årestedt, K. (2017). Beware of the origin of numbers: Standard scoring of the SF-12 and SF-36 summary measures distorts measurement and score interpretations. Research in nursing & health, 40(4), 378–386. Hagell, P., Westergren, A., & Årestedt, K. (2017). Beware of the origin of numbers: Standard scoring of the SF-12 and SF-36 summary measures distorts measurement and score interpretations. Research in nursing & health, 40(4), 378–386.
21.
go back to reference Ware, J. E., Jr., & Gandek, B. (1998). Overview of the SF-36 health survey and the International quality of life assessment (IQOLA) project. Journal of Clinical Epidemiology, 51(11), 903–912.PubMed Ware, J. E., Jr., & Gandek, B. (1998). Overview of the SF-36 health survey and the International quality of life assessment (IQOLA) project. Journal of Clinical Epidemiology, 51(11), 903–912.PubMed
22.
go back to reference Gandek, B., Ware, J. E., Aaronson, N. K., Apolone, G., Bjorner, J. B., Brazier, J. E., et al. (1998). Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: Results from the IQOLA Project: International Quality of Life Assessment. Journal of Clinical Epidemiology, 51(11), 1171–1178.PubMed Gandek, B., Ware, J. E., Aaronson, N. K., Apolone, G., Bjorner, J. B., Brazier, J. E., et al. (1998). Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: Results from the IQOLA Project: International Quality of Life Assessment. Journal of Clinical Epidemiology, 51(11), 1171–1178.PubMed
23.
go back to reference Butt, Z., Peipert, J., Webster, K., Chen, C., & Cella, D. (2013). General population norms for the functional assessment of cancer therapy-kidney symptom index (FKSI). Cancer, 119(2), 429–437.PubMed Butt, Z., Peipert, J., Webster, K., Chen, C., & Cella, D. (2013). General population norms for the functional assessment of cancer therapy-kidney symptom index (FKSI). Cancer, 119(2), 429–437.PubMed
24.
go back to reference Cella, D., Yount, S., Du, H., Dhanda, R., Gondek, K., Langefeld, K., et al. (2006). Development and validation of the functional assessment of cancer therapy-kidney symptom index (FKSI). J Support Oncol, 4(4), 191–199.PubMed Cella, D., Yount, S., Du, H., Dhanda, R., Gondek, K., Langefeld, K., et al. (2006). Development and validation of the functional assessment of cancer therapy-kidney symptom index (FKSI). J Support Oncol, 4(4), 191–199.PubMed
25.
go back to reference Rao, D., Butt, Z., Rosenbloom, S., Robinson, D., Von Roenn, J., Kuzel, T. M., et al. (2009). A comparison of the renal cell carcinoma-symptom index (RCC-SI) and the functional assessment of cancer therapy-kidney symptom index (FKSI). Journal of Pain and Symptom Management, 38(2), 291–298.PubMedPubMedCentral Rao, D., Butt, Z., Rosenbloom, S., Robinson, D., Von Roenn, J., Kuzel, T. M., et al. (2009). A comparison of the renal cell carcinoma-symptom index (RCC-SI) and the functional assessment of cancer therapy-kidney symptom index (FKSI). Journal of Pain and Symptom Management, 38(2), 291–298.PubMedPubMedCentral
27.
go back to reference Cumming, G. (2013). Cohen’s d needs to be readily interpretable: Comment on Shieh (2013). Behavior Research Methods, 45(4), 968–971.PubMed Cumming, G. (2013). Cohen’s d needs to be readily interpretable: Comment on Shieh (2013). Behavior Research Methods, 45(4), 968–971.PubMed
28.
go back to reference Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press. Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press.
29.
go back to reference Rosseel, Y. (2012). lavaan: An R package for structural equation modeling. Journal of Statistical Software, 48(2), 1–36. Rosseel, Y. (2012). lavaan: An R package for structural equation modeling. Journal of Statistical Software, 48(2), 1–36.
30.
go back to reference Hu, L. T., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Structural Equation Modeling-a Multidisciplinary Journal, 6(1), 1–55. Hu, L. T., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Structural Equation Modeling-a Multidisciplinary Journal, 6(1), 1–55.
32.
go back to reference SAS Institute Inc. (2014). SAS/STAT® 13.2 User’s Guide. Cary, NC: SAS Institute Inc. SAS Institute Inc. (2014). SAS/STAT® 13.2 User’s Guide. Cary, NC: SAS Institute Inc.
33.
go back to reference Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2004). The truly remarkable universality of half a standard deviation: Confirmation through another look. Expert Review of Pharmacoeconomics & Outcomes Research, 4(5), 581–585. Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2004). The truly remarkable universality of half a standard deviation: Confirmation through another look. Expert Review of Pharmacoeconomics & Outcomes Research, 4(5), 581–585.
34.
go back to reference Nielens, H., Lejeune, T. M., Lalaoui, A., Squifflet, J. P., Pirson, Y., & Goffin, E. (2001). Increase of physical activity level after successful renal transplantation: A 5 year follow-up study. Nephrology Dialysis Transplantation, 16(1), 134–140. Nielens, H., Lejeune, T. M., Lalaoui, A., Squifflet, J. P., Pirson, Y., & Goffin, E. (2001). Increase of physical activity level after successful renal transplantation: A 5 year follow-up study. Nephrology Dialysis Transplantation, 16(1), 134–140.
35.
go back to reference Goedendorp, M. M., Hoitsma, A. J., Bloot, L., Bleijenberg, G., & Knoop, H. (2013). Severe fatigue after kidney transplantation: A highly prevalent, disabling and multifactorial symptom. Transplant International, 26(10), 1007–1015.PubMed Goedendorp, M. M., Hoitsma, A. J., Bloot, L., Bleijenberg, G., & Knoop, H. (2013). Severe fatigue after kidney transplantation: A highly prevalent, disabling and multifactorial symptom. Transplant International, 26(10), 1007–1015.PubMed
36.
go back to reference Rodrigue, J. R., Mandelbrot, D. A., Hanto, D. W., Johnson, S. R., Karp, S. J., & Pavlakis, M. (2011). A cross-sectional study of fatigue and sleep quality before and after kidney transplantation. Clinical Transplantation, 25(1), E13–21.PubMed Rodrigue, J. R., Mandelbrot, D. A., Hanto, D. W., Johnson, S. R., Karp, S. J., & Pavlakis, M. (2011). A cross-sectional study of fatigue and sleep quality before and after kidney transplantation. Clinical Transplantation, 25(1), E13–21.PubMed
37.
go back to reference Tsay, S.-L. (2004). Acupressure and fatigue in patients with end-stage renal disease–a randomized controlled trial. International Journal of Nursing Studies, 41(1), 99–106.PubMed Tsay, S.-L. (2004). Acupressure and fatigue in patients with end-stage renal disease–a randomized controlled trial. International Journal of Nursing Studies, 41(1), 99–106.PubMed
38.
go back to reference Ju, A., Strippoli, G. F. M., Craig, J. C., Tong, A., Saglimbene, V. M., & Unruh, M. L. (2018). Interventions for fatigue in people with chronic kidney disease requiring dialysis. Cochrane Database of Systematic Reviews (8). Ju, A., Strippoli, G. F. M., Craig, J. C., Tong, A., Saglimbene, V. M., & Unruh, M. L. (2018). Interventions for fatigue in people with chronic kidney disease requiring dialysis. Cochrane Database of Systematic Reviews (8).
39.
go back to reference Perlman, R. L., & Rao, P. S. (2014). Quality of life of older patients undergoing renal transplantation: finding the right immunosuppressive treatment. Drugs & Aging, 31(2), 103–109. Perlman, R. L., & Rao, P. S. (2014). Quality of life of older patients undergoing renal transplantation: finding the right immunosuppressive treatment. Drugs & Aging, 31(2), 103–109.
40.
go back to reference Knoll, G. A. (2013). Kidney transplantation in the older adult. American Journal of Kidney Diseases, 61(5), 790–797.PubMed Knoll, G. A. (2013). Kidney transplantation in the older adult. American Journal of Kidney Diseases, 61(5), 790–797.PubMed
41.
go back to reference Mierzynska, J., Piccinin, C., Pe, M., Martinelli, F., Gotay, C., Coens, C., et al. (2019). Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: A systematic review. The Lancet Oncology, 20(12), e685–e698.PubMed Mierzynska, J., Piccinin, C., Pe, M., Martinelli, F., Gotay, C., Coens, C., et al. (2019). Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: A systematic review. The Lancet Oncology, 20(12), e685–e698.PubMed
42.
go back to reference Bottomley, A., Pe, M., Sloan, J., Basch, E., Bonnetain, F., Calvert, M., et al. (2016). Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: A start in setting international standards. The lancet Oncology, 17(11), e510–e514.PubMed Bottomley, A., Pe, M., Sloan, J., Basch, E., Bonnetain, F., Calvert, M., et al. (2016). Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: A start in setting international standards. The lancet Oncology, 17(11), e510–e514.PubMed
43.
go back to reference Perlman, R. L., Finkelstein, F. O., Liu, L., Roys, E., Kiser, M., Eisele, G., et al. (2005). Quality of life in Chronic Kidney Disease (CKD): A cross-sectional analysis in the Renal Research Institute-CKD study. American Journal of Kidney Diseases, 45(4), 658–666.PubMed Perlman, R. L., Finkelstein, F. O., Liu, L., Roys, E., Kiser, M., Eisele, G., et al. (2005). Quality of life in Chronic Kidney Disease (CKD): A cross-sectional analysis in the Renal Research Institute-CKD study. American Journal of Kidney Diseases, 45(4), 658–666.PubMed
44.
go back to reference Abdel-Kader, K., Unruh, M. L., & Weisbord, S. D. (2009). Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clinical Journal of the American Society of Nephrology, 4(6), 1057–1064.PubMedPubMedCentral Abdel-Kader, K., Unruh, M. L., & Weisbord, S. D. (2009). Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clinical Journal of the American Society of Nephrology, 4(6), 1057–1064.PubMedPubMedCentral
Metagegevens
Titel
Trends and predictors of multidimensional health-related quality of life after living donor kidney transplantation
Auteurs
John D. Peipert
Juan Carlos Caicedo
John J. Friedewald
Michael M. I. Abecassis
David Cella
Daniela P. Ladner
Zeeshan Butt
Publicatiedatum
13-04-2020
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 9/2020
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-020-02498-2

Andere artikelen Uitgave 9/2020

Quality of Life Research 9/2020 Naar de uitgave